Best Hyperthermic Intraperitoneal Chemotherapy (HIPEC) doctors: TOP 33 doctors

• Dr. Abdulcabbar Kartal specializes in HIPEC for abdominal cancers.
• Uses innovative HIPEC methods: cytoreductive surgery, closed abdomen technique, early postoperative intraperitoneal chemotherapy.
• Trained internationally; holds a HIPEC course certificate from 2017.
• Member of Turkish Association of Endoscopic Laparoscopic Surgery.
• Certified by Turkish Surgical Association in 2014.
• Provides online consultations for HIPEC inquiries.
• Fluent in Turkish and proficient in English.

• Dr. Mustafa Solak specializes in Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
• Performs HIPEC using latest methods: heated chemotherapy, precision drug delivery, and cytoreductive surgery.
• International training at The University of Texas MD Anderson Cancer Center in the U.S.
• Board-certified oncologist with fellowship from Hacettepe University Cancer Institute.
• Member of renowned oncology societies, ensuring updated HIPEC techniques.
• Offers online consultations for global HIPEC patients.
• Fluent in English and Turkish for diverse patient communication.

Assoc. Prof. Kıvanç Derya Peker is a surgeon with expertise in pancreatic, gallbladder, liver, and stomach surgeries. He also specializes in obesity and metabolic surgery, as well as kidney transplantation. He completed his medical and surgical training at Istanbul University. He ranked among the top three in the national minor specialty exam for gastroenterological surgery.

Dr. Peker has performed over 400 pancreatic and gastric cancer surgeries and more than 200 liver surgeries. He has also completed many gallbladder, biliary tract, obesity-metabolic procedures, and kidney transplants. He received training at the Mayo Clinic. He co-founded the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Hospital. There, he provided advanced training to surgical residents.

He is known for his research in aging and stem cell treatments. Dr. Peker has established gastroenterology surgery clinics at major hospitals. He is accredited by the Turkish HPB Association and has received a scholarship from the Turkish Surgery Association.

Dr. Pelles Sharon is an oncologist known for her skill in advanced cancer treatments and clinical research. She has led important studies on how cancer patients view and understand clinical trials. Her work has helped improve patient involvement and outcomes.

Dr. Sharon performs surgeries for colon and stomach cancer, HIPEC, SIRT therapy, and Whipple surgery. She also offers modern treatments such as immunotherapy, targeted therapy, and chemoembolization. She is respected for her high success rates and dedication to evidence-based care.

• Dr. Lana Bijelic specializes in HIPEC, treating peritoneal carcinomatosis.
• Performs HIPEC with advanced techniques: CRS, bidirectional chemotherapy, real-time monitoring.
• International HIPEC training in the USA, Spain, and Croatia.
• Certified by the American Board of Surgery, expertise in surgical oncology.
• Member of Society of Surgical Oncology, American College of Surgeons.
• Offers remote consultations for global HIPEC patients.
• Speaks English, Spanish, and Croatian fluently.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal system
• International Society for the treatment of tumors of the connective tissue

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Dr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, ​​1983) and which earned him the National Research Prize (1983).

Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team.

His area of ​​interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports.

Professional experience

1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain

1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain.

1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain.

1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona.

1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, ​​Spain.

From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation.

2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, ​​Spain.

2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, ​​Spain.

2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia.

Awards :

- National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands."

- National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells"

- National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A."

- American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999.

- Award for the most important technical innovation of 1999 from the Spanish Society.

Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999.

- 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000.

- Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA.

- Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research.

- Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique"

Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil.

Membership in scientific societies

Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO).

Member of the editorial board of Ophthalmology Times. Europe.

Member of the editorial board of Cataract and Refractive Surgery (USA).

Member of the Editorial Board of Cataract and Refractive Surgery Today Europe.

Member of the European Society of Cataract and Refractive Surgery (ESCRS).

Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.

• Dr. Domenico Sabia specializes in HIPEC, a targeted chemotherapy treatment.
• Performs HIPEC using innovative techniques: cytoreductive surgery, PIPAC.
• International training in Spain and Italy, enhancing HIPEC expertise.
• Accredited in advanced laparoscopic and robotic surgical methods.
• Member of GECOP and PSOGI, focusing on peritoneal malignancies.
• Offers online consultations for global HIPEC patient accessibility.
• Fluent in multiple languages, facilitating diverse patient communication.

• Dr. Phd Viola Fox specializes in Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
• Performs HIPEC by circulating heated chemotherapy in the abdominal cavity.
• Innovative HIPEC methods: real-time monitoring, pressurized intraperitoneal aerosol chemotherapy (PIPAC).
• International training in onco-surgery, with a focus on peritoneal carcinomatosis.
• Holds certifications in hematology, oncology, and genetic specialization.
• Member of German Society for Oncology (GDHO) and the American Association for Cancer Research.
• Offers remote consultations for HIPEC patients in multiple languages.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Thomas Bachleitner-Hofmann is a leading visceral surgeon at Confraternitaet Private Hospital. He specializes in surgery for large and small intestine, peritoneal, and breast cancers. He is known for his advanced surgical skills and his focus on team-based cancer care.

He is a member of several professional organizations, including the American Society of Clinical Oncology, American Association for Cancer Research, European Society of Coloproctology, and the Austrian Breast and Colorectal Cancer Study Group. Dr. Bachleitner-Hofmann has received awards such as the Heinrich Treichl Prize, ACO-ASSO Award, AACR Aflac Award, Theodor Billroth Prize, and the Prize of the City of Vienna for his work in cancer research.

He was born in 1985 in Antalya. He completed his primary and secondary education in Antalya. Between 2003 and 2009, he studied at the Cerrahpaşa Medical Faculty of Istanbul University. In 2009, he started his residency in Obstetrics and Gynecology at the Istanbul Suleymaniye Obstetrics and Pediatrics Education and Research Hospital. During his residency, he worked in obstetrics, Gynecology, Oncology, Endoscopic Surgery, Perinatology (high-risk pregnancy), Infertility and Menopause units.

In 2011, he spent two months in India studying actively on laparoscopy at World Laparoscopy Hospital. In 2014, he received the title of Obstetrician and Gynecologist. In the same year, he came 2nd in Turkey in the examination for Minor Specialty in Medicine and started his minor residency in Gynecological Oncology Surgery at Istanbul University Cerrahpasa Faculty of Medicine, Department of Obstetrics and Gynecology.

In 2017, he worked for three months at Memorial Sloan Kettering Cancer Center in New York, United States. In 2018, he became a minor specialist in Gynecological Oncology Surgery. In the same year, the European Society of Gynecological Oncology awarded him the personally accredited European Gynecologist Oncologist certificate (3rd person in Turkey). For about 1.5 years, he served at Gazi Yaşargil Training and Research Hospital under the Obligation of Civil Service. In 2019, he participated in active surgery and cadaver work together with Michael Höckel, one of the pioneers of Gynecological Oncology at the University of Leipzig, Leipzig, Germany. That same year, he was a “visiting fellow” at the Catholic University of the Sacred Heart in Rome, Italy.

He was awarded the title of Associate Professor in August 2019. He participated in numerous national and international congresses, symposiums and workshops and served as guest speaker. His surgery videos have been selected as training videos by the European Society of Gynecological Oncology and are published on their site for doctors.

He has 56 international and 10 national publications. He was the editor of the Turkish translation of the book, which is considered the main international source in Gynecological Oncology. He is the author of 7 chapters of international and national books. He has over 100 works in Turkey and abroad as oral presentations, poster presentations and panel presentations. He is refereeing for internationally respected journals. He has a good command of English. He follows up and implements all developments in his field.

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).